Treatment of cryptosporidiosis: do we know what we think we know?
about
The gut microbiome in human immunodeficiency virus infectionNew drug target in protozoan parasites: the role of thioredoxin reductaseA review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseasesThe Cryptosporidium parvum KinomeCryptosporidium infection in solid organ transplantationAntiparasitic therapyA high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosisBurden of disease from cryptosporidiosis.Novel in vitro and in vivo models and potential new therapeutics to break the vicious cycle of Cryptosporidium infection and malnutrition.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theEpidemiology and molecular relationships of Cryptosporidium spp. in people, primates, and livestock from Western UgandaTreatment of Cryptosporidium: What We Know, Gaps, and the Way ForwardIntestinal parasitic infections in children presenting with diarrhoea in outpatient and inpatient settings in an informal settlement of Nairobi, KenyaHigh-risk enteric pathogens associated with HIV infection and HIV exposure in Kenyan children with acute diarrhoeaAntimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal.Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in BangladeshThe state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.Cryptosporidiosis: A Disease of Tropical and Remote Areas in Australia.Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice.Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro.Enteric protozoa in the developed world: a public health perspective.Revisiting the reference genomes of human pathogenic Cryptosporidium species: reannotation of C. parvum Iowa and a new C. hominis reference.INTESTINAL AND PULMONARY INFECTION BY Cryptosporidium parvum IN TWO PATIENTS WITH HIV/AIDSThe Cryptosporidium parvum C-Type Lectin CpClec Mediates Infection of Intestinal Epithelial Cells via Interactions with Sulfated ProteoglycansIdentification and characterization of Cryptosporidium parvum Clec, a novel C-type lectin domain-containing mucin-like glycoprotein.A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexansNitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination.Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.Revisiting the global problem of cryptosporidiosis and recommendationsKilling of Cryptosporidium sporozoites by Lactoferrin.Translational readthrough-promoting drugs enhance pseudoknot-mediated suppression of the stop codon at the Moloney murine leukemia virus gag–pol junction.Individual subject meta-analysis of parameters for Cryptosporidium parvum shedding and diarrhoea in animal experimental models.A day at the pool.The in vitro and ex vivo effect of Auranta 3001 in preventing Cryptosporidium hominis and Cryptosporidium parvum infection.Targeted gene knockdown validates the essential role of lactate dehydrogenase in Cryptosporidium parvum.Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate
P2860
Q26743543-8DEE92C6-5E06-4C9F-ACBE-5A296FAC2628Q26781548-F39DDE23-E4EC-431D-8E0B-BEE35B3E1AD8Q26851900-126A2B81-082D-449E-81EB-452C1472C08AQ27003233-A591D10E-7130-4C73-81A0-752BD064163DQ27674622-578B76FF-14C3-4584-8D1B-14DED4F9CD8EQ28069815-AA7A2CA1-C1DE-4E9D-8C23-C62CBE976FE9Q28239164-3B4CDB01-EFDF-4DB6-BC08-056F4633608AQ30361870-C39EAA39-D57E-424A-89A4-ACE1DA72397EQ30384769-1F164EC0-743D-462C-9641-E124B11F6688Q30419620-E38966BD-6349-4F76-99F0-F139C045EB2EQ34212799-891DFF27-52FC-41FC-BA63-8CA2D13D9E07Q34233916-A87F8553-9EEF-4F0C-B1AD-59011C490FBEQ34501816-92E1CD94-BD93-49D1-9CAF-A6DDDBEBAC1FQ34738688-4CC472F1-52E5-4E42-9AFA-F3AA3F154247Q35136908-6A8D49AE-A1F6-42C3-A0F4-EAFE4C746A42Q35557331-F9B990EC-CBA8-442C-9175-84A1E162802DQ35716428-56A67DD3-C0BE-4F06-AC2E-9574D318608BQ35739010-EEDBDD7E-3328-406B-B05B-D2C501E285ADQ35783040-94C029FF-D863-4FDC-9EA5-8880DEA9B5DAQ35951126-CDD21C5A-C6FC-4A58-BC0B-9026CE476C15Q36097893-769A34B1-084C-4519-9A14-82CDCCB759D8Q36098066-D7BB4813-111C-452E-8488-2C65C4822488Q36156094-46B8AFF7-3974-43AA-BE22-82EC52483459Q36262448-017B0D56-B196-4634-BDD0-91FF53BE0F55Q36720386-A76971A1-A66F-47B6-A6B0-FDDB5530690FQ36888570-203C3265-99C3-4A3D-87A0-B978BD3205ADQ37123702-36154B64-E7B2-42E7-AB17-05A3895722B1Q37187522-AC5D23FB-79E4-467D-AB07-CF53E3F72C0EQ37315680-F483933C-7557-437C-B551-E50CF45FBC9CQ37390491-0426F35A-BFEC-446D-93B9-A84C6DB00F69Q37643702-3E8B58AF-CBEF-4548-A724-1EE878D60CB9Q37724846-AD07BEC8-EC34-4EFB-8E12-4CB5D549C654Q38672467-41D80F12-DA89-4CAF-904A-2ADECDE00AC4Q38834522-57439202-C0F3-4F66-A021-599C9202EC75Q39535894-DACC497D-E61D-445E-80EA-8B72B5D84D7AQ39719937-9A946013-E4EB-42C4-A67D-1D6A1EA3091EQ40061411-D1CEFEB2-FD62-4F14-BE77-ABD320B82566Q40175397-F584DEF2-0530-45E1-8484-75F9F7143A32Q40421224-B7A3383A-495A-43C4-A0F1-0F77803BC819Q41323286-5B21C7B8-4EEA-4835-AD3F-D1158D6E6466
P2860
Treatment of cryptosporidiosis: do we know what we think we know?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of cryptosporidiosis: do we know what we think we know?
@en
Treatment of cryptosporidiosis: do we know what we think we know?
@nl
type
label
Treatment of cryptosporidiosis: do we know what we think we know?
@en
Treatment of cryptosporidiosis: do we know what we think we know?
@nl
prefLabel
Treatment of cryptosporidiosis: do we know what we think we know?
@en
Treatment of cryptosporidiosis: do we know what we think we know?
@nl
P1476
Treatment of cryptosporidiosis: do we know what we think we know?
@en
P2093
Miguel M Cabada
P304
P356
10.1097/QCO.0B013E32833DE052
P577
2010-10-01T00:00:00Z